DiaSorin
DiaSorin Gets FDA 510(k) for Molecular COVID-19/Flu Assay
The real-time RT-PCR Simplexa COVID-19 & Flu A/B Direct assay is designed for use on the company's Liaison MDX instrument, with results in about one hour.
In Brief This Week:, Bio-Techne, DermTech, Cue Health, DiaSorin, Devyser, More
News items for the week of Feb. 27, 2023.
Top Five Articles on 360Dx Last Week: OraSure Restructuring; DiaSorin Divestiture; and More
Last week, readers were most interested in OraSure's plans to combine its Molecular Solutions and Diagnostics businesses and eliminate some positions.
DiaSorin Selling Luminex Flow Cytometry Business to Cytek Biosciences for $46.5M
The cash deal for the DiaSorin subsidiary's flow cytometry and imaging business adds to Cytek's technological capabilities and global reach.
Siemens Healthineers, Roche, Beckman Coulter, Abbott Gain FDA 510(k) Clearances in December
The agency cleared tests to help predict cardiovascular disease, rule out causes of Alzheimer's disease, provide early pregnancy detection, and identify prior drug use, among other uses.